Lensar (LNSR) EPS (Diluted) Growth (1y) (2022 - 2026)
Lensar (LNSR) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 13.96% |
| 10 | Lensar | 101.45 Mn | 87.89 Mn | 9.78 Mn | 162.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.35% |
| Mar 31, 2026 | 152.81% |
| Dec 31, 2025 | 92.49% |
| Sep 30, 2025 | -138.17% |
| Jun 30, 2025 | 81.29% |
| Mar 31, 2025 | -1,126.06% |
| Dec 31, 2024 | -353.74% |
| Sep 30, 2024 | -207.99% |
| Jun 30, 2024 | 2.38% |
| Mar 31, 2024 | 52.48% |
| Dec 31, 2023 | -46.00% |
| Sep 30, 2023 | 130.71% |
| Jun 30, 2023 | -20.56% |
| Mar 31, 2023 | 40.46% |
| Dec 31, 2022 | 41.12% |
| Sep 30, 2022 | 40.14% |
| Jun 30, 2022 | -43.00% |